Introduction
Inflammation has been suggested to play a role in the pathophysiology of anxiety. In particular, the inflammatory marker C-reactive protein (CRP) has been linked to anxiety across a number of studies [1, 2, 3, 4, 5, 6, 7, 8, 9] . In addition, both anxiety and CRP have been separately linked to obesity [10, 11] . A 2010 meta-analysis by Gariepy et al. demonstrated an overall increased odds of anxiety among adult men and women with obesity across 16 studies (pooled odds ratio 1.4, 95% confidence interval 1.2-1.6), and a 2013 meta-analysis by Choi et al. demonstrated an overall positive correlation between CRP protein and body mass index (BMI) across 51 studies (pooled Pearson correlation 0.36, 95% confidence interval 0.30-0.42) [10, 11] . These studies raise the question as to what role obesity plays in the relationship between anxiety and CRP. Pierce et al. (2017) investigated this relationship in a cohort of 100 adult men and women with obesity and demonstrated a positive correlation between anxiety and CRP, which remained robust after adjusting for BMI [9] . This association between anxiety and elevated CRP independent of BMI suggests that there may be a direct effect of inflammation in the pathogenesis of anxiety, which has been noted across a small number of other studies as well [4, 8, 9] .
For this reason, this current study seeks to investigate the role of BMI in the association between anxiety and CRP in a nationally representative general US population cohort. The primary aim of this study was to examine the association between anxiety and CRP and determine whether this association is moderated by BMI.
Previous studies have also noted an association between elevated CRP and depression [12, 13, 14, 15, 16, 17] . In addition, studies by Tayefi et al. and Duivis et al. suggest that this relationship may also be influenced by BMI [3, 4] . For this reason, we secondarily sought to examine the association between depression and CRP and determine whether this association is moderated by BMI.
Methods

Participant sample
This cross-sectional analysis uses existing data from the National Health and Nutrition Examination Survey (NHANES) public use data files NHANES is a rigorous, large-scale, long-running, general population research initiative by the Centers for Disease Control and Prevention (CDC) to collect data about the US general population for vital and health statistics via anthropometric measurement, blood samples, interview, and self-report questionnaire. While NHANES has been in operation for more than 60 years, beginning with the 1959-1962 National Health Examination Survey (NHES I), mental health was first captured as a component of NHANES beginning with NHANES III (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) and continuing on through current iterations. The NHANES III mental health survey evaluated symptoms of depression and mania only, using the 1981 Diagnostic Interview Schedule (DIS). Following the end of NHANES III in 1999, NHANES began running continuously in two-year cycles [18] . Beginning in 1999 and continuing through the current cycle, mental health began to be captured via the Composite International Diagnostic Interview (CIDI) instead, with the reasoning that the CIDI is more suitable than the DIS in large epidemiologic studies like NHANES because it can be administered by lay personnel. The mental health survey for NHANES 1999 onward captures depression, generalized anxiety disorder, and panic disorder only.
Anxiety
Our primary exposure of interest was anxiety. Anxiety data were collected as a component of NHANES via the CIDI, a questionnaire developed based on ICD-10 and DSM-IV criteria to capture 12-month prevalence of generalized anxiety disorder (GAD) and panic disorder. For the purposes of this study, and in accordance with previous work conducted by Hickman et al. [19] , the primary exposure of anxiety was defined as the presence of GAD and/or panic disorder (combined as 'anxiety disorder') as captured by the CIDI.
The secondary exposure of interest was major depression. Depression data were collected as a component of NHANES via the CIDI, which captured 12-month prevalence of major depression.
C-reactive protein
The outcome measure CRP was collected via blood draw as a component of NHANES and was reported in mg/dL. CRP was modeled as a continuous log-transformed variable, with values below the lower detection limit imputed by NHANES as the lower detection limit divided by √2. As a sensitivity analysis, CRP was dichotomized above or below the detection limit of 0.22 mg/dL, in keeping with the methods of Ford et al. [12] CRP concentrations at or above 0.22 mg/dL were present in 698 participants (48.5%).
Statistical analysis
Regression analyses were modeled with anxiety as the independent (predictor) variable and CRP as the dependent (response) variable. CRP was modeled first as a continuous variable and next as a dichotomous variable with a cutpoint of 0.22 mg/dL, using linear and logistic regression models respectively. Statistical analyses were conducted first with unadjusted models, followed by multivariable-adjusted models that adjusted for the effects of age, race, sex, smoking status, education, physical activity level, stroke, myocardial infarction, diabetes, hyperlipidemia, and hypertension. Moderation by obesity (defined as BMI 30 kg/m 2 ) was assessed through the inclusion of an anxiety*obesity interaction term, followed by stratified analyses to follow-up on any significant or marginally significant interaction. We also modeled continuous BMI and weight classes (underweight <18.5, normal weight 18.5-24.9, overweight 25.0-29.9, class I obesity 30.0-34.9, class II obesity 35.0-39.9, class III obesity 40.0-49.9, class IV obesity 50.0-59.9, class V obesity >60.0) and to assess for potential non-linear influences of obesity on the anxiety-CRP relationship. All statistical analyses were conducted using SAS 9.4.
Results
Descriptive analysis
A total of 1,439 NHANES participants ages 20-39 with non-missing CRP, anxiety, and depression data were available for this analysis. Of these, there were a total of 59 participants with anxiety (4.1%) as captured by the CIDI. Participants with anxiety were more likely than those without anxiety to be tobacco users and have a history of stroke (Table 1) .
Secondary analysis revealed 105 participants with depression (7.3%). Participants with depression were more likely than those without depression to be white, be tobacco users, and have a history of hypertension (Table 1) .
Anxiety and C-reactive protein
Linear regression failed to reveal any association between anxiety and CRP in unadjusted (β ¼ Table 2 ). In sensitivity analysis, multivariable-adjusted logistic regression failed to reveal any association between anxiety and elevated CRP (>0.22 mg/dL) (p ¼ 0.30).
Depression and C-reactive protein
In secondary analysis, linear regression failed to reveal any association between depression and CRP in unadjusted (β ¼ 0.20, se ¼ 0.14, p ¼ 0.16) or multivariable-adjusted analysis (β ¼ 0.12, se ¼ 0.13, p ¼ 0.38), nor was there evidence of moderation by obesity (p ¼ 0.26), categorical BMI (p ¼ 0.59), or continuous BMI (p ¼ 0.99) ( Table 2 ). In sensitivity analysis, multivariable-adjusted logistic regression failed to reveal any association between depression and elevated CRP (>0.22 mg/dL) (p ¼ 0.67).
Post-hoc power calculation
Our analyses were adequately powered to detect small to medium main effects. Under the assumptions of an independent samples t-test, at an alpha of 0.05, post hoc power calculations suggest 80% power to detect an effect size of 0.37 SD for CRP in anxiety and an effect size of 0.28 SD for CRP in depression.
Discussion
This study examined the association between anxiety and CRP and its relation to obesity in 1,439 members of the NHANES 1999-2004, a largescale general population US cohort. This study revealed no association between anxiety and CRP, which lies in contrast to the existing body of literature [4, 5, 6, 7, 8, 9, 16] . This may be because previous studies were conducted among larger cohorts [5, 6] and special populations [7, 8, 9] , which may have greater statistical power and larger effect sizes, respectively.
This study also failed to detect an association between depression and CRP. Our sensitivity analysis findings contrast those reported Ford et al., who found major depression to be associated with higher CRP [12] . This difference may due to the use of different NHANES cohorts. participants with complete data -which in turn may have led to inconsistencies in the ability to detect an association, as it has been noted that the effect size tends to be small [20] . While we appeared grossly powered to detect small to medium main effects, power may be effectively over-estimated with the high lower detection limit for the CRP assay used.
A strength of this study is its use of NHANES, a nationwide general population cohort. This study, however, is limited in its ability to capture CRP concentrations more granularly in that approximately half of the CRP measures were below the detectable level, potentially influencing our ability to detect an effect and leading to an overestimation of statistical power. Additionally, the relatively low prevalence of anxiety as measured in the cohort impacted the sample size, and the cross-sectional nature of our study limits its ability to assess temporality.
Despite its nonsignificant findings, this study is a valuable contribution to the body of literature. Future general population studies will require larger samples or should include more individuals with clinically significant anxiety to be sufficiently powered to detect small effects to determine the relation between anxiety and CRP. In addition, future studies may benefit from the use of high-sensitivity CRP, which is better suited to detect milder, sub-clinical inflammation, and is therefore a more sensitive measure than CRP. There is also a need for prospective studies in this area to better discern the temporal relationships between anxiety and inflammation.
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